Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 27

Results For "Director"

2714 News Found

Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening
News | November 19, 2025

Time Medical launches India’s first low-field TOF MRI for nationwide aneurysm screening

India presents one of the world’s largest untapped opportunities for neurovascular screening


Remedium Lifecare posts consolidated Q2 FY26 net profit higher at Rs. 8.62 Cr
News | November 17, 2025

Remedium Lifecare posts consolidated Q2 FY26 net profit higher at Rs. 8.62 Cr

Consolidated revenue from operations stood at Rs. 111.05 crore


AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India
News | November 17, 2025

AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India

Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names


Indian pharma sector poised for a global leap beyond generics: K. Raja Bhanu, DG, PHARMEXCIL
News | November 17, 2025

Indian pharma sector poised for a global leap beyond generics: K. Raja Bhanu, DG, PHARMEXCIL

With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards


WHO issues first global guidelines for managing diabetes in pregnancy
Healthcare | November 17, 2025

WHO issues first global guidelines for managing diabetes in pregnancy

Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases


Glenmark posts 72.2% jump in Q2 FY net profit at Rs. 610.4 Cr YoY
News | November 16, 2025

Glenmark posts 72.2% jump in Q2 FY net profit at Rs. 610.4 Cr YoY

EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025


Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr
News | November 16, 2025

Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr

Total income for the period stood at Rs. 7101.28 crore


Amcor launches ultra-light Shadow roll-on for next-gen beauty branding
Packaging | November 16, 2025

Amcor launches ultra-light Shadow roll-on for next-gen beauty branding

The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design


Merck to acquire Cidara Therapeutics for $9.2 billion
Biotech | November 15, 2025

Merck to acquire Cidara Therapeutics for $9.2 billion

Diversifying its portfolio to include late-phase antiviral agent